VoxNeuro

VoxNeuro is a private neurotechnology and software-as-a-medical-device company developing EEG-based brain performance software for objective cognitive assessment. Its core platform, the Cognitive Health Assessment Management Platform (CHAMP), combines neuropsychological testing with EEG and event-related potential biomarkers to generate clinician-friendly reports on memory, attention, and information processing. The company's first in-clinic product, VoxNeuro CORE, is positioned as an adjunctive cognitive assessment aid rather than a standalone diagnostic tool, and it is registered with the FDA and Health Canada. VoxNeuro appears to be commercial-stage, with installations and commercial expansion focused on North America, particularly the United States and Canada. The company has also described ongoing development of machine-learning enhancements and academic validation work in concussion and Alzheimer's disease.